Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy. Issue 2 (28th January 2021)

Record Type:: Journal Article
Title:: Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy. Issue 2 (28th January 2021)
Main Title:: Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy
Authors:: Lee, Sangmin
Desai, Pinkal
Edirisinghe, Bianca
Pianello, Samantha
Curcio, Tania
Samuel, Michael
Ritchie, Ellen K.
Roboz, Gail J.
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 62:Issue 2(2021)
Journal:: Leukemia & lymphoma
Issue:: Volume 62:Issue 2(2021)
Issue Display:: Volume 62, Issue 2 (2021)
Year:: 2021
Volume:: 62
Issue:: 2
Issue Sort Value:: 2021-0062-0002-0000
Page Start:: 498
Page End:: 500
Publication Date:: 2021-01-28
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2020.1832674 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 22849.xml